Drug Shortage Report for MOVISSE
| Report ID | 151687 |
| Drug Identification Number | 02410303 |
| Brand name | MOVISSE |
| Common or Proper name | NORETHINDRONE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | NORETHINDRONE |
| Strength(s) | 0.35MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28BL |
| ATC code | G03AC |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2021-12-17 |
| Estimated end date | 2022-01-05 |
| Actual end date | 2021-12-30 |
| Shortage status | Resolved |
| Updated date | 2022-01-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-01-04 | French | Compare |
| v3 | 2022-01-04 | English | Compare |
| v2 | 2021-12-21 | French | Compare |
| v1 | 2021-12-21 | English | Compare |
Showing 1 to 4 of 4